Business
Notice of Results and Investor Presentation
ProBiotix Health plc has announced that its audited results for the year ended 31 December 2025 will be released on Monday, 30 March 2026. The company's Chief Executive and Chief Finance Officer will present these results via Investor Meet Company on the same day at 10:00 BST, offering an opportunity for existing and potential shareholders to ask questions. Disclaimer*
About this update from Probiotix Health Plc
[{"type":"text","content":"\n\n16 March 2026\n \nProBiotix Health plc\n(\"ProBiotix\" or the \"Company\" or, together with its subsidiary, the \"Group\")\n \nNotice of Results and Investor Presentation\n \nProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, today confirms that it will release its audited results for the year ended 31 December 2025 on Monday, 30 March 2026.\n \nInvestor Presentation\n \nSteen Andersen, Chief Executive, and Mark Collingbourne, Chief Finance Officer, will provide a live presentation relating to the Full Year Results, via Investor Meet Company on 30 March 2026 at 10:00 BST.\n \nThe presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 29 March 2026, 09:00 BST, or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet ProBiotix Health via: https://www.investormeetcompany.com/probiotix-health-plc/register-investor\n \nInvestors who already follow ProBiotix Health on the Investor Meet Company platform will automatically be invited.\n \n \nFor further information, please contact:\n \n\n\n\n\nProBiotix Health plc\n\n\nhttps://probiotixhealth-ir.com/\n\n\n\n\n \n\n\[email protected]\n\n\n\n\nSteen Andersen, Chief Executive Officer\nMiles Nolan, Investor Relations\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\nAlbR Capital Limited\n \nAquis Corporate Adviser and Broker\n\n\nTel: 020 7469 0930\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\nThis announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abu...